CEFTRIAXONE SODIUM | A065204 | SANDOZ INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Hospira Inc. FDA-2011-P-0059 · 4 docket documents Hospira Inc. filed this citizen petition pursuant to FDC Act Section 505(j)(2)(C) and 21 CFR 314.93 requesting that FDA designate Sandoz's Ceftriaxone for Injection 1g and 2g in ADD-Vantage Vial (ANDA 065204) as an additional Reference Listed Drug so that generic applicants may submit ANDAs citing t | 505(q) | 2011-01-27 | Granted | Hospira Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.